rheumatologyadvisor23h
FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older
The U.S. Food and Drug Administration has expanded the age indication for Nerivio, making it the first and only remote electrical neuromodulation (REN) wearable for migraine treatment for children ...
rheumatologyadvisor23h
Majority of New Opioid Prescriptions in the UK Indicated for Musculoskeletal Conditions
New opioid prescriptions for patients in the UK mostly written for musculoskeletal conditions, in which there is little evidence for opioid efficacy.
rheumatologyadvisor23h
Psoriasiform Eruptions Are Common in Children With IBD Using TNF-α Inhibitors
Psoriasiform eruptions occur in approximately 12% of pediatric patients with inflammatory bowel disease using tumor necrosis α inhibitors.
rheumatologyadvisor23h
Opioid Use Treatment at Intervention Clinics Continues to Rise for Third Year
Opioid use disorder (OUD) treatment continued to increase in intervention clinics in the third year of implementation of the Massachusetts office-based addiction treatment (OBAT) model of nurse care ...
rheumatologyadvisor23h
Frailty Linked to Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus
Frailty among patients with SLE was linked to subclinical cardiovascular disease based on SLICC-FI scores — a tool that may aid in cardiovascular risk assessment.
rheumatologyadvisor23h
Young and Racially Diverse Adults With Chronic Pelvic Pain Face Lower Quality of Life
Young adults with chronic pelvic pain report a low quality of life compared to healthy individuals, with those of color having lower QOL.
rheumatologyadvisor23h
No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
HealthDay News — Menopausal hormone therapy (mHT) is not associated with long-term cognitive effects versus placebo, according to a study published online Nov. 21 in PLOS Medicine.